{'fraction_non_alphanumeric': 0.03452243958573072, 'fraction_numerical': 0.00805523590333717, 'mean_word_length': 4.958904109589041, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Multisystemic inflammatory syndrome post-COVID-19: A new emerging entity

Multisystem inflammatory syndrome in children (MISC-C), also known as the pediatric inflammatory multisystem syndrome, is a new dangerous childhood disease that may be associated with COVID disease. Signs and symptoms depend on the body part involved. We report a case of complicated post-COVID MIS-C in a 5-year-old child who presented with fever, vomiting, pain abdomen for 6 days, and rash for 2 days. Since the patient had complaints of high-grade fever for more than 5 days, rash, non-purulent conjunctivitis, cracked lips with cardiac and respiratory, and gastrointestinal involvement with positive COVID antibodies, and raised CRP; she was diagnosed to have the MIS-C post-COVID. The patient was started on oral aspirin and oral prednisolone for 2 weeks and discharged with proper advice.